Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy)

Trials

Volumn 15, Issue 1, 2014, Pages

  Eleftheriadou, Viktoria ^a   Thomas, Kim ^a   Ravenscroft, Jane ^b   Whitton, Maxine ^a   Batchelor, Jonathan ^a   Williams, Hywel ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Hand held phototherapy; Home phototherapy; Patient education; Randomised trial; Vitiligo

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ENGLAND; EQUIPMENT DESIGN; FEASIBILITY STUDIES; FEMALE; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SKIN PIGMENTATION; TIME FACTORS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO; YOUNG ADULT;

EID: 84893664300     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-51     Document Type: Article

References (17)

1. Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J, Young K. Guideline for the diagnosis and management of vitiligo. B J Dermatol 2008, 159(5):1051-1076.
2. Whitton ME, Pinart M, Batchelor J, Lushey C, Leonardi-Bee J, Gonzalez U. Interventions for vitiligo. Cochrane Database Syst Rev 2010, 1:CD003263.
3. Lee DY, Kim CR, Lee JH. Recent onset vitiligo on acral areas treated with phototherapy: need of early treatment. Photodermatol Photoimmunol Photomed 2010, 26(2):266-268.
4. Lee DY, Kim CR, Lee JH, Yang JM. Recent onset vitiligo treated with systemic corticosteroid and topical tacrolimus: need for early treatment in vitiligo. J Dermatol 2010, 37(12):1057-1059. 10.1111/j.1346-8138.2010.00929.x, 21083711.
5. Hallaji Z, Ghiasi M, Eisazadeh A, Damavandi MR. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed 2012, 28(3):115-119. 10.1111/j.1600-0781.2012.00648.x, 22548391.
6. Taieb A, Alomar A, Bohm M, Dell'anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G, Moretti S, Nieuweboer-Krobotova L, Olsson MJ, Parsad D, Passeron T, Tanew A, van der Veen W, van Geel N, Whitton M, Wolkerstorfer A, Picardo M. Guidelines for the Management of Vitiligo: the EDF consensus by the writing group of the Vitiligo European Task Force (VETF) in cooperation with the European Academy of Dermatology and Venereology (EADV) and the Union Europeenne des Medecins Specialistes (UEMS). B J Dermatol 2013, 168(1):5-19.
7. Ibbotson SH, Bilsland D, Cox NH, Dawe RS, Diffey B, Edwards C, Farr PM, Ferguson J, Hart G, Hawk J, Lloyd J, Martin C, Moseley H, McKenna K, Rhodes LE, Taylor DK. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. B J Dermatol 2004, 151(2):283-297.
8. Mysore V. Targeted phototherapy. Indian J Dermatol Venereol Leprol 2009, 75(2):119-125. 10.4103/0378-6323.48655, 19293497.
9. Yule S. Narrow-band UVB, (TL-01) phototherapy comb (Psoracomb) for scalp psoriasis treatment. Dermatolog Nurs 2005, 4:23-25.
10. Dotterud LK, Braun R. [UV-B comb versus betamethasone solution in scalp psoriasis]. Tidsskr Nor Laegeforen 2000, 120(16):1858-1859.
11. Caccialanza M, Piccinno R, Cappio M, Rozza M, Mainardi L. [Phototherapy of psoriasis of the scalp. Results in 21 patients treated with a special portable ultraviolet rays lamp]. Giornale Italiano Dermatologia Venereologia 1989, 124(11-12):LXI-LXV.
12. Eleftheriadou V, Whitton ME, Gawkrodger DJ, Batchelor J, Corne J, Lamb B, Ersser S, Ravenscroft J, Thomas KS. Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership. B J Dermatol 2011, 164(4):530-536.
13. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Experim Dermatol 1994, 19(3):210-216.
14. Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. B J Dermatol 1995, 132(6):942-949.
15. Augustin M, Gajura AI, Reich C, Rustenbach SJ, Schaefer I. Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire. Dermatol 2008, 217(2):101-106.
16. Porter J, Beuf AH, Lerner A, Nordlund J. Response to cosmetic disfigurement: patients with vitiligo. Cutis 1987, 39(6):493-494.
17. Lim-Ong M, Leveriza RM, Ong BE, Frez ML. Comparison between narrow-band UVB with topical corticosteroid and narrow-band UVB with placebo in the treatment of vitiligo: a randomized controlled trial. J Phillipine Dermatol Soc 2005, 14:17-22.